Table 3.
Summary of pooled effects at follow-up
| Outcome | Trials | Participants | Effect size (95% CI) | Heterogeneity: I 2 ; Chi 2 (p value) | Follow-up (months post-treatment ) | GRADE confidence rating |
|---|---|---|---|---|---|---|
|
Peer support |
4 |
1723 |
|
|
|
|
| Hospitalisation |
0 |
N/A |
N/A |
N/A |
N/A |
N/A |
| Symptoms of psychosis [45] |
1 |
448 |
SMD = -0.00 (-0.19, 0.18) |
N/A |
6 |
Low 4,5 |
| Employment |
0 |
N/A |
N/A |
N/A |
N/A |
N/A |
| Quality of life [45,50] |
2 |
639 |
SMD = -0.24 (-0.40, -0.08) |
0%; 0.00 (p = 0.98) |
3-6 |
Very low1, 4, 5 |
| Depression and anxiety [37,45] |
2 |
721 |
SMD = -0.17 (-0.32, -0.03) |
0%; 0.15 (p = 0.70) |
6 |
Low4,5 |
| Overall psychiatric symptoms [45] |
1 |
448 |
SMD = -0.08 (-0.26, 0.11) |
N/A |
6 |
Low4,5 |
| Recovery [45,46] |
2 |
757 |
SMD = -0.23 (-0.37, -0.09) |
0%, 0.71 (p = 0.40) |
6 |
Low4,5 |
| Hope [45,46,50] |
3 |
967 |
SMD = -0.24 (-0.46, -0.02) |
65%; 5.74 (p = 0.06) |
3-6 |
Very low1,2,4,5 |
| Empowerment [46,50] |
2 |
538 |
SMD = -0.25 (-0.43, -0.07) |
12%; 1.13 (p = 0.29) |
6 |
Very low1,4,5 |
| Satisfaction | 0 | N/A | N/A | N/A | N/A | N/A |
Reasons for downgrade: 1Risk of bias, 2Inconsistency, 3Indirectness, 4Imprecision, 5Publication/Reporting Bias.
RR Relative Risk, SMD Standardised Mean Difference.